|[December 12, 2013]
Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Insys Therapeutics, Inc.
SAN DIEGO --(Business Wire)--
Shareholder rights law firm Johnson & Weaver, LLP has commenced an
investigation into whether certain officers and directors of Insys
Therapeutics, Inc. (NASDAQ: INSY) violated state or federal laws.
On December 12, 2013, after the markets closed, Insys Therapeutics
revealed that it had received a subpoena from the Office of Inspector
General of the Department of Health and Human Services ("HHS") in
connection with an investigation of potential violations involving HHS
programs. The subpoena requests documents regarding Subsys®, including
Insys' sales and marketing practices relating to the product.
Since this news announcement, shares ofInsys Therapeutics have fallen
29% in after-market trading.
If you have information that could assist in this investigation, or if
you are a Insys Therapeutics shareholder and are interested in learning
more about the investigation or your legal rights and remedies, please
contact Jim Baker (firstname.lastname@example.org) by
email or by phone at 619-230-0063, Ext. 118.
Johnson & Weaver, LLP is a nationally recognized shareholders' rights
law firm. The firm represents individual and institutional investors in
shareholder derivative and securities class action lawsuits. For more
information about the firm and its attorneys, please visit http://www.johnsonandweaver.com.
[ Back To Technology News's Homepage ]